Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Director departure
MALACHITE INNOVATIONS, INC. (VBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 8-K Quarterly results
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/31/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MALACHITE INNOVATIONS REPORTS FIRST QUARTER 2023 RESULTS"
05/04/2023 4 FEIGHAN EDWARD F (Director) has filed a Form 4 on MALACHITE INNOVATIONS, INC.
Txns: Bought 1,000 shares @ $0.1845, valued at $184.5
Bought 5,000 shares @ $0.1987, valued at $993.5
Bought 10,000 shares @ $0.1988, valued at $2k
Bought 2,000 shares @ $0.1951, valued at $390.2
Bought 2,000 shares @ $0.2, valued at $400
Bought 30,000 shares @ $0.2, valued at $6k
04/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/13/2023 8-K Quarterly results
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/31/2023 5 Celeste Richard F (Director) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
03/31/2023 5 Cavanaugh Michael R. (CEO) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
03/31/2023 5 Zipp Brandon Joel (Chief Science Officer) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
03/31/2023 5 MCKILLIGAN RICHARD (CFO) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
03/31/2023 5 FEIGHAN EDWARD F (Director) has filed a Form 5 on MALACHITE INNOVATIONS, INC.
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
09/22/2022 8-K/A Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Independent Registered Public Accounting Firm",
"Financial Statements Page Independent Auditor’ s Report F-2 Balance Sheets as of December 31, 2021 and December 31, 2020 F-3 Statements of Operations for the years ended December 31, 2021 and December 31, 2020 F-4 Statements of Stockholders’ Equity for the years ended December 31, 2021 and December 31, 2020 F-5 Statements of Cash Flows for the years ended December 31, 2021 and December 31, 2020 F-6 Notes to Financial Statements F-7 F- 1 Independent Auditor’ s Report To the Shareholders of Range Environmental Resources, Inc.",
"Malachite Innovations, Inc. Pro Forma Consolidated Balance Sheet Malachite Innovations Inc. Range Environmental Resources, Inc. Pro Forma Adjustments Pro Forma Total Current assets Cash $ 44,162 $ 87,058 $ - $ 131,220 Accounts receivable, net - 853,311 - 853,311 Prepaid expenses 884 - - 884 Total current assets 45,046 940,369 - 985,415 Property and equipment, net of accumulated depreciation - 400,886 182,114 583,000 Deposits 8,892 - - 8,892 Operating lease asset - 130,630 - 130,630 Goodwill - - 779,165 779,165 Total Assets 53,938 1,471,885 961,279 2,487,102 Current liabilities Accounts payable and accrued liabilities 133,553 286,998 - 420,551 Current portion of long-term debt - 49,625 - 49,625 Line of Credit 750,000 - - 750,000 Total current liabilities 883,553 336,623 - 1,220,176 Long-ter..."
08/29/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "FORM OF WARRANT NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED , AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES. COMMON STOCK..."
08/16/2022 8-K Quarterly results
08/16/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
07/15/2022 8-K Quarterly results
06/01/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/27/2022 SC 13D/A LoConti Joseph E. reports a 37.4% stake in Malachite Innovations, Inc.
05/18/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/13/2022 8-K Quarterly results
05/12/2022 4 LoConti Joseph E. (10% Owner) has filed a Form 4 on MALACHITE INNOVATIONS, INC.
Txns: Bought 6,666,667 shares @ $0.15, valued at $1M
Granted 6,666,667 warrants @ $0.6, valued at $4M
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
03/31/2022 10-KT Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
03/15/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MALACHITE INNOVATIONS ANNOUNCES SIGNED LETTER OF INTENT WITH RANGE ENVIRONMENTAL RESOURCES, INC. 15 MAR 2022 / PRESS RELEASE",
"LETTER OF INTENT"
03/09/2022 8-K Quarterly results
12/28/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MALACHITE INNOVATIONS ANNOUNCES TWO GRANTED U.S. PATENTS AND NEW PCT PATENT FILING CLEVELAND, OHIO – – MALACHITE INNOVATIONS, INC. announces that its wholly-owned drug development subsidiary, Graphium Biosciences, Inc., has been granted two patents by the U.S. Patent and Trademark Office for its cannabinoid glycoside prodrug, and has filed a new patent under the Patent Cooperation Treaty for its novel manufacturing process used to produce its proprietary cannabinoid glycosides. The Company's new patent application was filed with the USPTO and preserves our right to seek patent protection in 153 foreign nations that are signatories of the PCT. Granted: Cannabinoid Glycoside Prodrugs and Methods of Synthesis Graphium Biosciences has been granted a patent by the USPTO for its “Cannabinoid Gly..."
12/13/2021 4 FEIGHAN EDWARD F (Director) has filed a Form 4 on MALACHITE INNOVATIONS, INC.
Txns: Granted 250,000 options to buy @ $0.277, valued at $69.3k
12/13/2021 4 Zipp Brandon Joel (Chief Science Officer) has filed a Form 4 on MALACHITE INNOVATIONS, INC.
Txns: Disposed/sold 2,500 options to buy @ $4.2, valued at $10.5k
Disposed/sold 7,500 options to buy @ $4.4, valued at $33k
Disposed/sold 15,000 options to buy @ $4.2, valued at $63k
Disposed/sold 20,000 options to buy @ $3.4, valued at $68k
Disposed/sold 20,000 options to buy @ $2.1, valued at $42k
Disposed/sold 75,000 options to buy @ $1.81, valued at $135.8k
Granted 127,487 options to buy @ $0.277, valued at $35.3k
Granted 22,513 options to buy @ $0.277, valued at $6.2k
12/13/2021 4 Cavanaugh Michael R. (CEO) has filed a Form 4 on MALACHITE INNOVATIONS, INC.
Txns: Granted 350,000 options to buy @ $0.277, valued at $97k
12/13/2021 4 Celeste Richard F (Director) has filed a Form 4 on MALACHITE INNOVATIONS, INC.
Txns: Granted 250,000 options to buy @ $0.277, valued at $69.3k
12/13/2021 4 MCKILLIGAN RICHARD (CFO) has filed a Form 4 on MALACHITE INNOVATIONS, INC.
Txns: Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 20,000 options to buy @ $3.4, valued at $68k
Disposed/sold 20,000 options to buy @ $2.1, valued at $42k
Disposed/sold 75,000 options to buy @ $1.81, valued at $135.8k
Granted 114,769 options to buy @ $0.277, valued at $31.8k
Granted 35,231 options to buy @ $0.277, valued at $9.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy